内含埃博拉病毒GP基因序列假病毒粒子的构建及应用
Construction and Application of Pseudovirions Containing Ebola Virus GP Gene Sequence
DOI: 10.12677/ACM.2024.142651, PDF,    科研立项经费支持
作者: 龙云凤, 祝 贺, 陆冠亚, 赵晓燕, 姜 焱*:南京海关动植物与食品检测中心,江苏 南京;陈金霞, 叶银波, 白吉山:南京农业大学动物医学院,江苏 南京
关键词: 埃博拉假病毒GP基因荧光定量PCREbola Virus GP Gene Fluorescence Quantitative PCR
摘要: 目的:构建内含埃博拉病毒(EBOV) GP基因序列的假病毒粒子,针对EBOV GP基因建立实时荧光定量PCR检测方法。方法:人工合成GP基因序列,克隆至慢病毒包装载体pGWLV-pseudovirus中,转化DH5α感受态细胞,筛选得到阳性克隆pGWLV-GP质粒。将重组质粒转染293T细胞,培养48 h后进行除菌,纯化后获得高纯度假病毒,通过RT-PCR鉴定该假病毒粒子含有EBOV GP基因。通过荧光定量qPCR对假病毒颗粒进行计数后,利用本研究所获得的假病毒颗粒制备用于EBOV核酸检测的标准品。结果:建立了基于EBOV GP基因的Taqman荧光定量PCR检测方法。结论:该方法所用标准品模拟了真实病毒粒子的结构,无生物传染性,经检测均匀性和稳定性良好,可作为EBOV核酸检测的阳性标准质控品,实现对核酸检测的全程监控。
Abstract: Objective: To construct pseudovirion containing Ebola virus (EBOV) GP gene sequence and establish EBOV Taqman real-time fluorescence quantitative PCR detection assay. Methods: The GP gene se-quence was synthesized and cloned into lentivirus packaging vector PGWLV-pseudovirus, trans-formed into DH5α competent cells and screened to obtain a positive clone of pGWLV-GP plasmid. The recombinant plasmid was transfected into 293T cells, cultured for 48 h, and purified to obtain a high purity pseudovirus, which was identified by RT-PCR as containing the EBOV GP gene. After counting pseudovirus particles by fluorescence quantitative qPCR, the pseudovirus particles ob-tained in this study were used to prepare standards for EBOV nucleic acid detection. Results: A Taqman real-time PCR method based on EBOV GP gene was established. Conclusion: The standard substance used in this method simulates the structure of real virions, has good uniformity and sta-bility after detection, and can be used as positive standard quality control substance for EBOV nu-cleic acid detection, realizing the whole process monitoring of nucleic acid detection.
文章引用:龙云凤, 陈金霞, 祝贺, 陆冠亚, 赵晓燕, 叶银波, 白吉山, 姜焱. 内含埃博拉病毒GP基因序列假病毒粒子的构建及应用[J]. 临床医学进展, 2024, 14(2): 4706-4713. https://doi.org/10.12677/ACM.2024.142651

参考文献

[1] Jacob, S.T., Crozier, I., Fisher, W.A., et al. (2020) Ebola Virus Disease. Nature Reviews Disease Primers, 6, Article Number: 13. [Google Scholar] [CrossRef] [PubMed]
[2] Heymann, D.L., Weisfeld, J.S., Webb, P.A., et al. (1980) Ebola Hemorrhagic Fever: Tandala, Zaire, 1977-1978. The Journal of Infectious Diseases, 142, 372-376. [Google Scholar] [CrossRef] [PubMed]
[3] Alexander, K.A., Sanderson, C.E., Marathe, M., et al. (2015) What Factors Might Have Led to the Emergence of Ebola in West Africa. PLOS Neglected Tropical Diseases, 9, e0003652. [Google Scholar] [CrossRef] [PubMed]
[4] Elmahdawy, M., Elsisi, G.H., Carapinha, J., et al. (2017) Ebola Virus Epidemic in West Africa: Global Health Economic Challenges, Lessons Learned, and Policy Recommendations. Value in Health Regional Issues, 13, 67-70. [Google Scholar] [CrossRef] [PubMed]
[5] Goeijenbier, M., Van Kampen, J.J., Reusken, C.B., et al. (2014) Ebola Virus Disease: A Review on Epidemiology, Symptoms, Treatment and Pathogenesis. The Netherlands Journal of Medicine, 72, 442-448.
[6] Nicastri, E., Kobinger, G., Vairo, F., et al. (2019) Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention. Infectious Disease Clinics of North America, 33, 953-976. [Google Scholar] [CrossRef] [PubMed]
[7] 林婧, 胡啟龙, 王尚君, 等. 假病毒标准物质在传染性病毒核酸检测质量控制中的应用[J]. 计量与测试技术, 2021, 48(2): 1-2+5.
[8] World Health Organization (2022) Ebola Vi-rus Disease.
https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease
[9] Chippaux, J.P. (2014) Outbreaks of Ebola Virus Disease in Africa: The Beginnings of a Tragic Saga. Journal of Venomous Animals and Toxins including Tropical Diseases, 20, Article Number: 44. [Google Scholar] [CrossRef] [PubMed]
[10] Li, Q., Liu, Q., Huang, W., et al. (2018) Current Status on the De-velopment of Pseudoviruses for Enveloped Viruses. Reviews in Medical Virology, 28, e1963. [Google Scholar] [CrossRef] [PubMed]
[11] Pasloske, B.L., Walkerpeach, C.R., Obermoeller, R.D., et al. (1998) Ar-mored RNA Technology for Production of Ribonuclease-Resistant Viral RNA Controls and Standards. Journal of Clin-ical Microbiology, 36, 3590-3594. [Google Scholar] [CrossRef
[12] Feldmann, H., Volchkov, V.E., Volchkova, V.A., et al. (2001) Biosynthesis and Role of Filoviral Glycoproteins. Journal of General Virology, 82, 2839-2848. [Google Scholar] [CrossRef] [PubMed]
[13] Jeffers, S.A., Sanders, D.A. and Sanchez, A. (2002) Covalent Modifications of the Ebola VIRUS Glycoprotein. Journal of Virology, 76, 12463-12472. [Google Scholar] [CrossRef
[14] Volchkov, V.E., Feldmann, H., Volchkova, V.A., et al. (1998) Processing of the Ebola Virus Glycoprotein by the Proprotein Convertase Furin. Proceedings of the National Academy of Sciences of the United States of America, 95, 5762-5767. [Google Scholar] [CrossRef] [PubMed]